TWD 51.5
(-2.83%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 3.03 Billion TWD | 284.18% |
2022 | 790.56 Million TWD | 58.58% |
2021 | 498.52 Million TWD | -14.41% |
2020 | 582.43 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 3.24 Billion TWD | 6.83% |
2024 Q2 | 3.14 Billion TWD | -3.04% |
2023 Q3 | 2.81 Billion TWD | 111.11% |
2023 FY | 3.03 Billion TWD | 284.18% |
2023 Q1 | 1.04 Billion TWD | 31.71% |
2023 Q2 | 1.33 Billion TWD | 28.11% |
2023 Q4 | 3.03 Billion TWD | 7.85% |
2022 Q4 | 790.56 Million TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Allied Biotech Corporation | 2.07 Billion TWD | -46.096% |
GeneFerm Biotechnology Co., Ltd. | 1.17 Billion TWD | -158.402% |
Easywell Biomedicals, Inc. | 1.21 Billion TWD | -150.225% |
TTY Biopharm Company Limited | 9.87 Billion TWD | 69.243% |
Synmosa Biopharma Corporation | 11.72 Billion TWD | 74.104% |
Orient EuroPharma Co., Ltd. | 10.81 Billion TWD | 71.909% |
Center Laboratories, Inc. | 27 Billion TWD | 88.752% |
Tien Liang BioTech Co., Ltd. | 654.03 Million TWD | -364.377% |
Orient Pharma Co., Ltd. | 2.56 Billion TWD | -18.516% |
InnoPharmax Inc. | 524.19 Million TWD | -479.4% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 1.99 Billion TWD | -52.397% |
Excelsior Biopharma Inc. | 1.57 Billion TWD | -92.553% |
DV Biomed Co., Ltd. | 1.81 Billion TWD | -67.556% |
Foresee Pharmaceuticals Co., Ltd. | 1.86 Billion TWD | -63.163% |
UniPharma Co., Ltd. | 350.07 Million TWD | -767.585% |
Anxo Pharmaceutical Co., Ltd. | 2.21 Billion TWD | -36.898% |
Alar Pharmaceuticals Inc. | 973.2 Million TWD | -212.081% |
Winston Medical Supply Co., Ltd. | 801.77 Million TWD | -278.808% |
Mercury Biopharmaceutical Corporation | 438.07 Million TWD | -593.304% |
Bioray Biotech Co., Ltd | 542.64 Million TWD | -459.698% |
TSH Biopharm Corporation Limited | 1.39 Billion TWD | -116.964% |